Sign in Sign up for free

Last updated: 27 June 2024 at 5:00pm EST

Susan Siegel Net Worth




The estimated Net Worth of Susan E Siegel is at least $2.78 Million dollars as of 17 May 2024. Ms. Siegel owns over 1,029 units of Illumina Inc stock worth over $977,419 and over the last 14 years she sold ILMN stock worth over $538,770. In addition, she makes $1,260,440 as Independent Director at Illumina Inc.

Ms. Siegel ILMN stock SEC Form 4 insiders trading

Susan has made over 10 trades of the Illumina Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently she exercised 1,029 units of ILMN stock worth $128,450 on 17 May 2024.

The largest trade she's ever made was exercising 65,000 units of Illumina Inc stock on 10 August 2011 worth over $45,500. On average, Susan trades about 2,618 units every 161 days since 2010. As of 17 May 2024 she still owns at least 7,830 units of Illumina Inc stock.

You can see the complete history of Ms. Siegel stock trades at the bottom of the page.





Susan Siegel biography

Susan E. (Sue) Siegel is Director of the Company. Ms. Siegel has more than 30 years of corporate, entrepreneurial and venture capital experience. Before joining GE, she was a General Partner at Mohr Davidow Ventures, where she led investments in personalized medicine, digital health and life sciences. Prior to that, Ms. Siegel served as president and board member at Affymetrix, steering the company's transformation from a pre-revenue startup to a global genomics leader with a multibillion-dollar market cap. Earlier, she held executive positions spanning functional disciplines at Bio-Rad, DuPont and Amersham. Ms. Siegel has served on more than a dozen private and public corporate boards in her career, including Pacific Biosciences and Affymetrix. Currently, she is a board member at Align Technologies and MIT’s The Engine. In addition, she co-chairs Stanford Medicine’s Board of Fellows and serves on advisory boards for Harvard Partners Healthcare Innovation, UC Innovation Council, RAND Health Care, and USC Marshall School Board of Leaders. Her non-profit board appointments have included the National Venture Capital Association and Silicon Valley’s Tech Museum of Innovation.

What is the salary of Susan Siegel?

As the Independent Director of Illumina Inc, the total compensation of Susan Siegel at Illumina Inc is $1,260,440. There are 6 executives at Illumina Inc getting paid more, with Mostafa Ronaghi having the highest compensation of $3,541,310.



How old is Susan Siegel?

Susan Siegel is 59, she's been the Independent Director of Illumina Inc since 2019. There are 8 older and 14 younger executives at Illumina Inc. The oldest executive at Illumina Inc is John Thompson, 71, who is the Lead Independent Director.

What's Susan Siegel's mailing address?

Susan's mailing address filed with the SEC is C/O NEVRO CORP., 1800 BRIDGE PARKWAY, REDWOOD CITY, CA, 94065.

Insiders trading at Illumina Inc

Over the last 21 years, insiders at Illumina Inc have traded over $412,190,379 worth of Illumina Inc stock and bought 13,386 units worth $1,243,499 . The most active insiders traders include John Wendell Thompson, Jay T Flatley, and Robert Nelsen. On average, Illumina Inc executives and independent directors trade stock every 5 days with the average trade being worth of $954,700. The most recent stock trade was executed by Jacob Thaysen on 22 February 2024, trading 7,330 units of ILMN stock currently worth $991,676.



What does Illumina Inc do?

at illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. these studies will help make the realization of personalized medicine possible. with such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. as a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. illumina’s innovative, array-based solutions for dna, rna, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.



What does Illumina Inc's logo look like?

Illumina Inc logo

Complete history of Ms. Siegel stock trades at Align Technology, Illumina Inc, Pacific Biosciences of California Inc, and Nevro Corp

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
17 May 2024 ALGN Align Technology, Inc. Susan E Siegel
Option 1,029 $271.50 $279,374
17 May 2024
7,830 ↗
17 May 2023 ALGN Align Technology, Inc. Susan E Siegel
Option 1,114 $291.36 $324,575
17 May 2023
6,801 ↗
18 May 2022 ALGN Align Technology, Inc. Susan E Siegel
Option 524 $269.11 $141,014
18 May 2022
5,687 ↗
19 May 2021 ALGN Align Technology, Inc. Susan E Siegel
Option 1,271 $571.49 $726,364
19 May 2021
5,163 ↗
12 Feb 2020 ALGN Align Technology, Inc. Susan E Siegel
Sale 1,400 $273.93 $383,502
12 Feb 2020
2,971 ↗
3 Feb 2020 ALGN Align Technology, Inc. Susan E Siegel
Sale 600 $258.78 $155,268
3 Feb 2020
4,371 ↗
15 May 2019 ALGN Align Technology, Inc. Susan E Siegel
Option 1,042 $325.71 $339,390
15 May 2019
4,971 ↗
16 May 2018 ALGN Align Technology, Inc. Susan E Siegel
Option 3,115 $287.96 $896,995
16 May 2018
3,929 ↗
17 May 2017 ALGN Align Technology, Inc. Susan E Siegel
Option 814 $136.08 $110,769
17 May 2017
814 ↗
10 Aug 2011 PACB Pacific Biosciences of California Inc Susan E Siegel
Director
 Option 65,000 $0.70 $45,500
10 Aug 2011
65,000 ↗


Illumina Inc executives and stock owners

Illumina Inc executives and other stock owners filed with the SEC include: